Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Other Current Liabilities

As of the most recent data (March 2026), ELAT shows a other current liabilities of $1.2B. That compares with $570M in the prior-year period — up 115.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELAT's other current liabilities is now $1.2B (was $570M) — a 115.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is outperforming or lagging.

Tracking ELAT's other current liabilities over time shows whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $570M in the prior-year period — up 115.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.2B) with ownership activity and broader fundamentals.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s other current liabilities is $1.2B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.